Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 5:01 PM ET

Date/Time Source News Release
09/01/2023 04:00 PM EDT Business Wire IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
07/26/2023 07:05 AM EDT Business Wire IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process
05/08/2023 04:30 PM EDT Business Wire IMV Receives NASDAQ Delisting Notice
05/02/2023 04:15 PM EDT PR Newswire Horizon Technology Finance Announces First Quarter 2023 Financial Results
05/01/2023 12:30 PM EDT Business Wire IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives
03/31/2023 04:15 PM EDT Business Wire IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
03/27/2023 04:15 PM EDT Business Wire IMV Inc. Announces Changes to Its Board of Directors
03/16/2023 07:05 AM EDT Business Wire IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results
03/09/2023 07:05 AM EST Business Wire IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023
02/13/2023 07:05 AM EST Business Wire IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial
Page

Additional News

As of June 3, 2025 • 5:01 PM ET

Date/Time Source News Release
06/22/2021 12:30 PM EDT Motley Fool Canada 3 Under-$5 TSX Stocks That Could Double in a Year
05/30/2021 10:15 AM EDT Motley Fool Canada Value Investing: 1 Pharma Stock to Buy in June 2021
12/09/2020 12:37 PM EST BTV Bulletin IMV: A New Type of Treatment for Cancer
04/04/2019 07:05 AM EDT Business Wire Canada IMV Inc. to Present at the Bloom Burton & Co. Healthcare Investor Conference; Announces Update to Presentation at H.C. Wainwright Investor Conference
03/26/2019 07:05 AM EDT Business Wire Canada Initial Phase 2 Data From an IMV Clinical Study Continues to Demonstrate DPX-Survivac's Prior Trend as a Potential Monotherapy Treatment for Advanced Ovarian Cancer
03/25/2019 07:05 AM EDT Business Wire Canada IMV Inc. to Present at Two Upcoming Investor Conferences
03/21/2019 05:05 PM EDT Business Wire Canada IMV Inc. Announces 2018 Year-end Financial and Operational Results and Provides Updates on Key Clinical Programs
03/18/2019 07:05 AM EDT Business Wire Canada IMV and Centre de Recherche du CHU de Québec-Université Laval Collaboration Awarded a CQDM Grant to Develop First-in-Class Dual Target T Cell Therapy in Bladder Cancer Based on IMV's DPX Technology
03/12/2019 07:05 AM EDT Business Wire Canada IMV Researchers to Present New Preclinical Data at AACR Annual Meeting 2019
03/06/2019 09:15 AM EST Business Wire Canada IMV Inc. Closes Previously Announced Public Offering
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.